{"id":"https://genegraph.clinicalgenome.org/r/a0ea00cf-677d-4dae-95a3-93688375927fv1.3","type":"EvidenceStrengthAssertion","dc:description":"*DDOST* was first reported in relation to autosomal recessive congenital disorder of glycosylation in 2012 (Jones et al., PMID 22305527). At least 7 unique variants (missense, frameshift) have been reported. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 4 probands from 4 publications (PMIDs 22305527, 33413482, 34462534, 36214423). Patients have a range of clinical features, including developmental delay, hypotonia, failure to thrive, eye abnormalities, gastrointestinal involvement, and liver dysfunction.  The disease mechanism appears to be biallelic loss of function. Heterozygous carriers are reportedly unaffected. This gene-disease relationship is supported by the biochemical function of DDOST, which encodes a subunit of the oligosaccharyl transferase complex (OST complex) which plays a key role in N-glycosylation (PMIDs 1600939, 37848450). Rescue experiments in patient fibroblasts demonstrated that wild type DDOST restores glycosylation (PMID 22305527). \n\nIn summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorders of Glycosylation Gene Curation Expert Panel on November 15, 2023 (SOP version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a0ea00cf-677d-4dae-95a3-93688375927f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab","calculatedEvidenceStrength":"Moderate","contributions":[{"agent":"https://genegraph.clinicalgenome.org/agent/10006","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2023-11-15T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-02-05T23:18:25.497Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc868a27-9107-40f7-9d61-4d17fd37fe45_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc868a27-9107-40f7-9d61-4d17fd37fe45","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36214423","rdfs:label":"Elsharkawi 2023 Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/164b2b84-60d4-40f7-acb4-4bebee8b5122","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005216.5(DDOST):c.1091dup (p.Leu364PhefsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2582115698"}},{"id":"https://genegraph.clinicalgenome.org/r/4109672b-dda4-478c-bfd1-e7063db567a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005216.5(DDOST):c.610T>C (p.Ser204Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338851553"}}],"detectionMethod":"Trio WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001251","obo:HP_0001336","obo:HP_0001288","obo:HP_0005425","obo:HP_0100022","obo:HP_0002072","obo:HP_0001263","obo:HP_0001332","obo:HP_0001337","obo:HP_0010543","obo:HP_0001317","obo:HP_0000490"],"previousTesting":true,"previousTestingDescription":"Serum carbohydrate deficient transferrin revealed elevated ratios of mono-oligo/di-oligosaccharide, and a-oligo/dioligosaccharide, suggestive of a diagnosis of type I CDG. Western blotting of fibroblasts showed decreased ICAM-1 and LAMP2 showed lower molecular weight with an increased spread, consistent with N-linked CDG.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/023545ca-bf49-423f-8d5f-5a9f181df6cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36214423","allele":{"id":"https://genegraph.clinicalgenome.org/r/164b2b84-60d4-40f7-acb4-4bebee8b5122"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/aa777040-e366-41da-a973-3d6087d8d67f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36214423","allele":{"id":"https://genegraph.clinicalgenome.org/r/4109672b-dda4-478c-bfd1-e7063db567a8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/023545ca-bf49-423f-8d5f-5a9f181df6cc","type":"EvidenceLine","dc:description":"Complementation assay showed that this variant does not restore N-glycosylation (PMID: 37848450). This was included under experimental evidence so not using it to change the score here.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/023545ca-bf49-423f-8d5f-5a9f181df6cc_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/aa777040-e366-41da-a973-3d6087d8d67f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa777040-e366-41da-a973-3d6087d8d67f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb377b76-93c1-4662-9471-70ea34b215de_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 affected individuals. Need 3 to score.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36631682","rdfs:label":"Sitek 2023 Siblings","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/bb377b76-93c1-4662-9471-70ea34b215de","type":"Family","rdfs:label":"Sitek 2023 Siblings","member":{"id":"https://genegraph.clinicalgenome.org/r/da46cb0e-237c-43ee-ab67-2e15171ac0af","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36631682","rdfs:label":"Starosta 2021 Patient 32","ageType":"AgeAtReport","ageUnit":"Years","ageValue":66,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/17ec1f42-6895-4f54-8ac6-f58fe7dd1c5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.11:g.20661382G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338856834"}},{"id":"https://genegraph.clinicalgenome.org/r/313121ec-adf5-4afe-95ae-5379b55ae160","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005216.5(DDOST):c.1274T>A (p.Phe425Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA18967630"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002014","obo:HP_0002719","obo:HP_0003010","obo:HP_0002571","obo:HP_0003394","obo:HP_0000821","obo:HP_0002066","obo:HP_0100806","obo:HP_0100658","obo:HP_0001513","obo:HP_0005425","obo:HP_0000846","obo:HP_0009900","obo:HP_0005363","obo:HP_0100279","obo:HP_0004850","obo:HP_0005978"],"previousTesting":true,"previousTestingDescription":"Western blot showed Glycosylated ICAM1 protein expression was 47% lower compared to the control; LAMP2 protein was 50% lower.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7a2b7047-68bc-4132-8476-395b1129d4d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36631682","allele":{"id":"https://genegraph.clinicalgenome.org/r/17ec1f42-6895-4f54-8ac6-f58fe7dd1c5d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/02b288e9-4bb5-4e9d-9c59-0e185db349dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36631682","allele":{"id":"https://genegraph.clinicalgenome.org/r/313121ec-adf5-4afe-95ae-5379b55ae160"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000821","obo:HP_0003010","obo:HP_0002571","obo:HP_0003394","obo:HP_0002014","obo:HP_0002719","obo:HP_0001513"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/da46cb0e-237c-43ee-ab67-2e15171ac0af"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d501c14a-9d2e-4426-8f03-3d86bb572444_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d501c14a-9d2e-4426-8f03-3d86bb572444","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33413482","rdfs:label":"Starosta 2021 Patient 32","ageType":"AgeAtReport","ageUnit":"Years","ageValue":65,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/17ec1f42-6895-4f54-8ac6-f58fe7dd1c5d"},{"id":"https://genegraph.clinicalgenome.org/r/313121ec-adf5-4afe-95ae-5379b55ae160"}],"detectionMethod":"Authors do not mention genotyping methods.","phenotypeFreeText":"Molecular confirmed diagnosis of CDG and biochemical confirmation of the specific defect. Bilirubin 1.5 mg/dL (normal <1.3).","phenotypes":["obo:HP_0011014","obo:HP_0001396","obo:HP_0002904","obo:HP_0003119"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/36dd63fc-8cc5-445d-b446-98a8a06353cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33413482","allele":{"id":"https://genegraph.clinicalgenome.org/r/313121ec-adf5-4afe-95ae-5379b55ae160"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/deedbddb-8601-41c6-8968-4b9b4a05d08f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33413482","allele":{"id":"https://genegraph.clinicalgenome.org/r/17ec1f42-6895-4f54-8ac6-f58fe7dd1c5d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/deedbddb-8601-41c6-8968-4b9b4a05d08f","type":"EvidenceLine","dc:description":"Variants confirmed in trans","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/deedbddb-8601-41c6-8968-4b9b4a05d08f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/36dd63fc-8cc5-445d-b446-98a8a06353cb","type":"EvidenceLine","dc:description":"Not significantly different from wt in functional study. Variants confirmed in trans.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36dd63fc-8cc5-445d-b446-98a8a06353cb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/36dd63fc-8cc5-445d-b446-98a8a06353cb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 37848450 shows that p.Phe425Tyr was able to restore N-glycosylation in a complementation assay\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/da46cb0e-237c-43ee-ab67-2e15171ac0af_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da46cb0e-237c-43ee-ab67-2e15171ac0af"},{"id":"https://genegraph.clinicalgenome.org/r/7a2b7047-68bc-4132-8476-395b1129d4d4","type":"EvidenceLine","dc:description":"Proband already scored","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a2b7047-68bc-4132-8476-395b1129d4d4_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/02b288e9-4bb5-4e9d-9c59-0e185db349dc","type":"EvidenceLine","dc:description":"Proband already scored","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02b288e9-4bb5-4e9d-9c59-0e185db349dc_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ef0b3252-a56a-4a60-b2c8-47171dba1def_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef0b3252-a56a-4a60-b2c8-47171dba1def","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22305527","rdfs:label":"Jones 2012 Proband CDG-0235","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/22b4f947-bb86-47e7-b61f-9ae9611a3e77","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005216.5(DDOST):c.599G>A (p.Gly200Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259770"}},{"id":"https://genegraph.clinicalgenome.org/r/2039f49b-333c-4eec-967a-bd3127502c02","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005216.5(DDOST):c.1214_1235del (p.Ile405ThrfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259769"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Serum transferrin analyzed by ESI-MS and MALDI-TOF revealed type 1 pattern in which both monoglycosylated and aglycosylated transferrin were elevated. ","phenotypes":["obo:HP_0000938","obo:HP_0012447","obo:HP_0007301","obo:HP_0005616","obo:HP_0001410","obo:HP_0001337","obo:HP_0001508","obo:HP_0000486","obo:HP_0001263","obo:HP_0001252","obo:HP_0002020","obo:HP_0001976","obo:HP_0410018","obo:HP_0001929"],"previousTesting":true,"previousTestingDescription":"Targeted next-gen sequencing of 25 genes associated with CDG","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/63943899-05f8-483c-b02e-dffc49be2322_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22305527","allele":{"id":"https://genegraph.clinicalgenome.org/r/2039f49b-333c-4eec-967a-bd3127502c02"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/396f39e2-bda0-4dcb-bd5e-e7e841eca971_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22305527","allele":{"id":"https://genegraph.clinicalgenome.org/r/22b4f947-bb86-47e7-b61f-9ae9611a3e77"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/63943899-05f8-483c-b02e-dffc49be2322","type":"EvidenceLine","dc:description":"Frameshift in the last exon so NMD not expected. Immunoblot analysis on patient cells showed no smaller bands, suggesting that the truncated protein was unstable or degraded. Also complementation assay showed that this variant does not restore N-glycosylation (PMID: 37848450). ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63943899-05f8-483c-b02e-dffc49be2322_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/396f39e2-bda0-4dcb-bd5e-e7e841eca971","type":"EvidenceLine","dc:description":"Not significantly different from wt.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/396f39e2-bda0-4dcb-bd5e-e7e841eca971_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/396f39e2-bda0-4dcb-bd5e-e7e841eca971_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 37848450 shows that this variant was able to restore N-glycosylation in a complementation assay.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/a382d18f-47f9-4682-929e-aad1cb965d46_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a382d18f-47f9-4682-929e-aad1cb965d46","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34462534","rdfs:label":"Pi 2022 Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/ab68443e-2b6f-4ede-bbf2-64ffb77b9df7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005216.5(DDOST):c.1136G>A (p.Arg379Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA661019"}},"detectionMethod":"Trio WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Serum transferrin isoelectrofocusing demonstrated defective glycosylation. Dysmorphic facial features: broad forehead, brow ptosis, depressed nasal tip, thick lip, and low-set cup ears.","phenotypes":["obo:HP_0001252","obo:HP_0001696","obo:HP_0001508","obo:HP_0004789","obo:HP_0000486","obo:HP_0001263","obo:HP_0001999","obo:HP_0011968","obo:HP_0011003","obo:HP_0000483"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/151a7cf9-6c97-491b-906f-72911322dbc8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34462534","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab68443e-2b6f-4ede-bbf2-64ffb77b9df7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/151a7cf9-6c97-491b-906f-72911322dbc8","type":"EvidenceLine","dc:description":"Not significantly different from wt.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/151a7cf9-6c97-491b-906f-72911322dbc8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/151a7cf9-6c97-491b-906f-72911322dbc8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 37848450 shows that this variant was able to restore N-glycosylation in a complementation assay.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.9},{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c65492a-146d-4d6b-a720-6af6084da91c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6eb2ced5-1139-4ea7-977e-612e5c00949b","type":"Finding","dc:description":"DDOST is part of the oligosaccharyltransferase complex(OST complex)which plays a key role in N-glycosylation. Therefore, the complex subunit mutations are considered as the genetic causes of CDGs.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1600939","rdfs:label":"Oligosaccharyl transferase activity","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3b15d042-ad98-4c4e-acf3-0ba018f2f123","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9836df93-35d2-4324-ab2d-2e752642c21a","type":"Finding","dc:description":"OST48 is a non-catalytic component of the oligosaccharyltransferase (OST) complex, which transfers glycans to substrate proteins. CDGs have a spectrum of clinical phenotypes caused by abnormal N-glycosylation. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37848450","rdfs:label":"Kas 2023 Biochemical function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1a1edfd-f110-49b4-a8fa-4e4002187598","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8bf9d30e-a037-4a90-9b6d-6da205136ffa","type":"FunctionalAlteration","dc:description":"LOX N-glycosylation was also restored by DDOST p.G200D, p.S206P and p.R379Q, but not by p.L364Ffs*11 or p.I405Tfs*7.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37848450","rdfs:label":"DDOST variants affect LOX N-glycosylation"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e0605b51-70c5-42ee-81b5-d45bb0b1fdab_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4207fd60-8265-4514-8914-be262865459c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54347a53-730d-4149-8e7c-89e13a2c21b2","type":"Finding","dc:description":"Complementation with wt DDOST in patient cells reduced the amount of GFP expression compared to patient cells complemented with mock vector, indicating that wt DDOST restores glycosylation. Also, patient cells complemented with wt DDOST had significantly increased ICAM-1 expression compared to patient cells complemented with mock vector. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22305527","rdfs:label":"Glycosylation rescue in patient cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Moderate","sequence":9937,"specifiedBy":"GeneValidityCriteria9","strengthScore":6.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/vH5XyoWmAak","type":"GeneValidityProposition","disease":"obo:MONDO_0013789","gene":"hgnc:2728","modeOfInheritance":"obo:HP_0000007"},"version":"1.3","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e0605b51-70c5-42ee-81b5-d45bb0b1fdab-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}